Catalyst Pharmaceuticals (CPRX) Cash from Investing Activities (2011 - 2026)
Catalyst Pharmaceuticals posted quarterly Cash from Investing Activities of -$27000.0 for Q1 2026, up 15.62% on a QoQ basis from -$32000.0 in Q4 2025.
Catalyst Pharmaceuticals (CPRX) has 16 years of Cash from Investing Activities data on file, last reported at -$27000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities changed N/A year-over-year to -$27000.0; the trailing twelve-month figure through Mar 2026 stood at -$85000.0 (up 76.19% YoY), and the FY2025 full-year result was -$58000.0, up 89.57% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$27000.0, up from -$32000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$10000.0 in Q2 2024 and bottomed at -$162.4 million in Q1 2023.
- The 5-year median for Cash from Investing Activities is -$132000.0 (2022), against an average of -$26.8 million.
- The widest annual swing landed in 2023, when Cash from Investing Activities tumbled 70215.91%; it then jumped 99.88% in 2024.
- A 5-year view of Cash from Investing Activities shows it stood at -$132000.0 in 2022, then tumbled by 28928.79% to -$38.3 million in 2023, then soared by 99.77% to -$88000.0 in 2024, then surged by 63.64% to -$32000.0 in 2025, then grew by 15.62% to -$27000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$27000.0 (Q1 2026), -$32000.0 (Q4 2025), and -$26000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | -27,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27,000.00 |
| Mar 31, 2026 | -27,000.00 |
| Dec 31, 2025 | -32,000.00 |
| Dec 31, 2025 | -32,000.00 |
| Jun 30, 2025 | -26,000.00 |
| Jun 30, 2025 | -26,000.00 |
| Dec 31, 2024 | -88,000.00 |
| Dec 31, 2024 | -88,000.00 |
| Sep 30, 2024 | -259,000.00 |
| Sep 30, 2024 | -259,000.00 |
| Jun 30, 2024 | -10,000.00 |
| Jun 30, 2024 | -10,000.00 |
| Mar 31, 2024 | -199,000.00 |
| Mar 31, 2024 | -199,000.00 |
| Dec 31, 2023 | -38.32 Mn |
| Dec 31, 2023 | -38.32 Mn |
| Sep 30, 2023 | -92.82 Mn |
| Sep 30, 2023 | -92.82 Mn |
| Mar 31, 2023 | -162.37 Mn |
| Mar 31, 2023 | -162.37 Mn |
| Sep 30, 2022 | -132,000.00 |
| Sep 30, 2022 | -132,000.00 |
| Dec 31, 2021 | -41,000.00 |
| Dec 31, 2021 | -41,000.00 |
| Sep 30, 2021 | -68,000.00 |
| Sep 30, 2021 | -68,000.00 |
| Jun 30, 2021 | -4.00 Mn |
| Jun 30, 2021 | -4.00 Mn |
| Mar 31, 2021 | -6.91 Mn |
| Mar 31, 2021 | -6.91 Mn |
| Sep 30, 2020 | -10.01 Mn |
| Sep 30, 2020 | -10.01 Mn |
| Mar 31, 2020 | 5.00 Mn |
| Mar 31, 2020 | 5.00 Mn |
| Dec 31, 2019 | 31.66 Mn |
| Dec 31, 2019 | 31.66 Mn |
| Sep 30, 2019 | 5.05 Mn |
| Sep 30, 2019 | 5.05 Mn |
| Jun 30, 2019 | -9.93 Mn |
| Jun 30, 2019 | -9.93 Mn |
| Mar 31, 2019 | 10.45 Mn |
| Mar 31, 2019 | 10.45 Mn |
| Dec 31, 2018 | 14.14 Mn |
| Dec 31, 2018 | 14.14 Mn |
| Sep 30, 2018 | 7.58 Mn |
| Sep 30, 2018 | 7.58 Mn |
| Jun 30, 2018 | -4.96 Mn |
| Jun 30, 2018 | -4.96 Mn |
| Mar 31, 2018 | -31.85 Mn |
| Mar 31, 2018 | -31.85 Mn |
| Dec 31, 2017 | 60,790.00 |
| Dec 31, 2017 | 60,790.00 |
| Sep 30, 2017 | -29,838.00 |
| Sep 30, 2017 | -29,838.00 |
| Jun 30, 2017 | -1,765.00 |
| Jun 30, 2017 | -1,765.00 |
| Mar 31, 2017 | -33,145.00 |
| Mar 31, 2017 | -33,145.00 |
| Dec 31, 2016 | 586,452.00 |
| Dec 31, 2016 | 586,452.00 |
| Sep 30, 2016 | 2.20 Mn |
| Sep 30, 2016 | 2.20 Mn |
| Jun 30, 2016 | 832,662.00 |
| Jun 30, 2016 | 832,662.00 |
| Mar 31, 2016 | -65,571.00 |
| Mar 31, 2016 | -65,571.00 |
| Dec 31, 2015 | 50,477.00 |
| Dec 31, 2015 | 50,477.00 |
| Sep 30, 2015 | -44,418.00 |
| Sep 30, 2015 | -44,418.00 |
| Jun 30, 2015 | 30,711.00 |
| Jun 30, 2015 | 30,711.00 |
| Mar 31, 2015 | -43,269.00 |
| Mar 31, 2015 | -43,269.00 |
| Dec 31, 2014 | -8,943.00 |
| Dec 31, 2014 | -8,943.00 |
| Sep 30, 2014 | 15,057.00 |
| Sep 30, 2014 | 15,057.00 |
| Jun 30, 2014 | -10.01 Mn |
| Jun 30, 2014 | -10.01 Mn |
| Mar 31, 2014 | 1.27 Mn |
| Mar 31, 2014 | 1.27 Mn |
| Dec 31, 2013 | -6.81 Mn |
| Dec 31, 2013 | -6.81 Mn |
| Sep 30, 2013 | -4.20 Mn |
| Sep 30, 2013 | -4.20 Mn |
| Jun 30, 2013 | 2.02 Mn |
| Jun 30, 2013 | 2.02 Mn |
| Mar 31, 2013 | 1.49 Mn |
| Mar 31, 2013 | 1.49 Mn |
| Dec 31, 2012 | -14.05 Mn |
| Dec 31, 2012 | -14.05 Mn |
| Sep 30, 2012 | -1.00 |
| Sep 30, 2012 | -1.00 |
| Jun 30, 2012 | -1,900.00 |
| Jun 30, 2012 | -1,900.00 |
| Mar 31, 2012 | -4,981.00 |
| Mar 31, 2012 | -4,981.00 |
| Dec 31, 2011 | 2.00 Mn |
| Dec 31, 2011 | 2.00 Mn |
| Sep 30, 2011 | -2,019.00 |
| Sep 30, 2011 | -2,019.00 |